Waters Corporation
HealthcareNYSE:WAT · New York Stock Exchange
-$4.16 today
Vol 0.44M · Avg 1.03M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
25.1%
avg 43.6%
ROIC
17.6%
avg 19.2%
ROA
12.7%
avg 15.0%
Analysis
ROE is currently the strongest return metric at 25.1% versus its period average of 43.6%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Udit Batra | President, Chief Executive Officer & Director | $3.54M | — | 55 | $33,140.00 | 0.05% |
Amol Chaubal | Senior Vice President & Chief Financial Officer | $1.42M | — | 49 | $7,622.84 | 0.01% |
Robert L. Carpio | Senior Vice President of Waters Analytical Sciences | $1.24M | — | 43 | $4,884.00 | <0.01% |
Jianqing Y. Bennett | Senior Vice President of Waters Advanced Diagnostics | $1.18M | — | 56 | $6,532.00 | 0.01% |
Keeley A. Aleman | Senior VP, General Counsel & Head of Global Human Resources | $897,333.00 | — | 49 | $200.74 | <0.01% |
Brook Colangelo | Senior VP & Chief Information Officer | — | — | 48 | — | — |
Christos Ross | Senior Vice President of Global Operations | — | — | — | — | — |
Steve Conly | Senior Vice President of Waters Biosciences | — | — | 42 | — | — |
Cheryl Kennedy | Senior Vice President of Human Resources | — | — | — | — | — |
Kristen Garvey | Senior Vice President of Global Communications | — | — | — | — | — |
Caspar Tudor | Head of Investor Relations | — | — | — | — | — |
Daniel Rush | SVP of Global Research & Strategy and Interim SVP of Water Materials Sciences | — | — | — | $1,355.00 | <0.01% |
Allan Jaenicke | Senior Vice President of Transformation | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
2
$451,070.00
Sells
0
$0.00
Net Sentiment
+$451,070.00
Net buying
Most Active
Jiang Wei
1 transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Jiang Wei Direct | Buy | 500 | $289.46 | $144,730.00 | |
| Mar 6, 2026 | FEARON RICHARD H Direct | Buy | 1.0K | $306.34 | $306,340.00 |
Analysis
Insiders reported 2 buys worth $451,070.00 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $451,070.00. Jiang Wei was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +2.9% | +9.2% (15yr)1 analysts |
| Revenue | N/A | N/A | +3.5% | +9.8% (15yr)13 analysts |
| Net Income | N/A | N/A | +0.5% | +6.9% (15yr)13 analysts |
| EBIT | N/A | N/A | +3.5% | +10.0% (15yr)13 analysts |
Analysis
Recent growth has been strongest in EBIT at +3.5% over three years. Forward estimates point to EBIT at +10.0% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
DexCom, Inc.
NASDAQ:DXCM
$28.77B
Illumina, Inc.
NASDAQ:ILMN
$24.39B
West Pharmaceutical Services, Inc.
NYSE:WST
$23.28B
Mettler-Toledo International Inc.
NYSE:MTD
$22.87B
Quest Diagnostics Incorporated
NYSE:DGX
$22.45B
Incyte Corporation
NASDAQ:INCY
$21.79B
Labcorp Holdings Inc.
NYSE:LH
$21.65B
STERIS plc
NYSE:STE
$20.27B
Zimmer Biomet Holdings, Inc.
NYSE:ZBH
$17.13B
Medpace Holdings, Inc.
NASDAQ:MEDP
$13.42B
Who manages WAT?
Waters Corporation (WAT) lists 13 active executives. The top listed executive is Amol Chaubal, Senior Vice President & Chief Financial Officer.
Are WAT insiders buying or selling?
Recent insider activity shows net buying of $59.67M.
Explore More
Continue the stock analysis
Jump to another research area for this company.